Search alternatives:
point decrease » point increase (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
82601
Table1_Placental treatment with insulin-like growth factor 1 via nanoparticle differentially impacts vascular remodeling factors in guinea pig sub-placenta/decidua.DOCX
Published 2023“…Additionally, there are no effective in utero treatment options for FGR. We have developed a nanoparticle to deliver human insulin-like 1 growth factor (hIGF-1) in a trophoblast-specific manner which results in increased expression of hIGF-1. …”
-
82602
Baseline characteristics for pneumonia.
Published 2024“…</p><p>Results</p><p>Models were generated for atrial fibrillation, venous thromboembolism and pneumonia as genetics only, clinical features only and a combined model. For venous thromboembolism, the ROC-AUCs were 60.1% [59.6%-60.4%], 63.4% [63.2%-63.4%] and 66.6% [66.2%-66.9%] for the linear models and 51.5% [49.4%-53.4%], 63.2% [61.2%-65.0%] and 62.6% [60.7%-64.5%] for the deep learning SNP, clinical and combined models, respectively. …”
-
82603
Complexes with Redox-Active Ligands: Synthesis, Structure, and Electrochemical and Photophysical Behavior of the Ru(II) Complex with TTF-Annulated Phenanthroline
Published 2013“…Ru(II) complexes with chelating ligands, 4′,5′-ethylenedithiotetrathiafulvenyl[4,5-<i>f</i>][1,10]phenanthroline (<b>L1</b>), 1,3-dithiole-2-thiono[4,5-<i>f</i>][1,10]phenanthroline (<b>L2</b>), and 1,3-dithiole-2-ono[4,5-<i>f</i>][1,10]phenanthroline (<b>L3</b>), have been prepared and their structural, electrochemical, and photophysical properties investigated. …”
-
82604
Supplemental material for Fig 2.
Published 2024“…(h) Quantification of the abundance of 561-Eos<sup>+</sup> microglia in <i>Tg(pu1</i>:<i>Eos)</i> animals that had all microglia photoconverted a 3 dpf and then quantified at 6 dpf. Each data point with connect line represent a single animal. …”
-
82605
Complementary conditioning measures in healthy subjects.
Published 2024“…<b>(F) Intake</b> volumes were higher for CS<sup>+</sup> than CS<sup>-</sup> (F<sub>(1,102)</sub> = 5.5, <i>P</i> = 0.02), and decreased across conditioning days (F<sub>(1,102)</sub> = 8.1, <i>P</i> = 0.005; Interaction: F<sub>(1,102)</sub> = 0.5, <i>P</i> = 0.5; repeated-measures 2-way ANOVA). …”
-
82606
Respiratory Exchange Ratio (RER) in ADKD and ADOX WT and OB mice.
Published 2013“…Data shown are mean ± SEM (8 mice per group) and run in a TSE systems indirect calorimeter for 48 hr. …”
-
82607
General Health Questionnaire (GHQ12): new evidence of construct validity
Published 2023“…The study included 1,085 physicians with a mean age of 45.7 (SD = 10.6), mostly male (61.5%), married (72.6%) and Catholic (59.2%). …”
-
82608
Reduced production of white blood cells (WBC) in <i>Iqgap2</i><sup><i>-/-</i></sup> mice.
Published 2015“…Data are presented as the mean ± SEM. N = 3 per genotype/treatment (<b>A</b>), N = 5 per genotype/treatment (<b>B</b>), p-values indicating statistically significant differences are shown.…”
-
82609
An attenuation of WP caused downregulation of MMP7 in PTEN null TNBC cells.
Published 2013“…Pharmacological attenuation of beta-catenin in PTEN null MMP7 expressing TNBC cell lines, MDA-MB468 (B i) and SUM149 (B ii) following the treatment with XAV939 (B i) and sulindac sulfide (B ii) caused a decrease in MMP7 protein expression as well as an abrogation of its enzymatic activity. …”
-
82610
Effects of aging and exposure to high-fat diet on spatial strategy use in the Barnes maze.
Published 2015“…<p>Spatial (<b>A,D,G</b>), serial (<b>B,E,H</b>) and mixed/random (<b>C,F,I</b>) strategy use by adult and aged mice on control diet (CD) and high-fat diet (HFD) on the Barnes maze acquisition days (a1-a5), retention day (Ret) and reversal learning days (Rv1-Rv2). …”
-
82611
CO suppression of LPS-induced IL-1β transcription, mRNA expression, and protein production.
Published 2009“…<p>(A) Nuclear run-on assays in THP-1 cells (2×10<sup>7</sup>) showed that CO represses IL-1β transcription by almost 98% within 30 min of LPS stimulation (p = 0.001) and the effect decreased to 67% at 60 min (p = 0.01). …”
-
82612
DHA treatment and genotype modulate active properties of EC deep layer neurons.
Published 2011“…<p>(A, B) Examples of recording trace showing voltage response to a 3-s depolarizing current at the excitation threshold (top trace) and 80±5 pA above the rheobase (bottom trace) from the same neuron of each group. …”
-
82613
Classification accuracy under fixed iterations.
Published 2023“…The classification accuracy of standard predictive coding slowly decreases over batches, illustrating a common pathology observed in these simulations. …”
-
82614
<i>LGG</i> protects against intestinal injury induced by PAF and LPS.
Published 2012“…PAF/LPS-treated mice that were pre-treated with <i>LGG</i> had lower intestinal injury scores than those pre-treated with vehicle alone (A), representative images are shown. Inflammatory cytokines MIP-2 and TNF-α were also measured by qRT-PCR after PAF/LPS and found to be decreased in the mice pre-treated with <i>LGG</i> (B). …”
-
82615
Effects of vaccination on HSA during dose reduction and reinstatement.
Published 2014“…<p>Median total heroin infusions in rats that acquired HSA and completed the dose-reduction protocol (left panel). Rats were trained at a heroin unit dose of 0.06 mg/kg/inf. The heroin dose was sequentially decreased every 5 days to 0.03, 0.01, 0.003 and 0 mg/kg to obtain a dose-response curve. …”
-
82616
Supplementary Material for: Quantification of Posterior Risk Related to Intrapartum FIGO 2015 Criteria for Cardiotocography in the Second Stage of Labor
Published 2021“…Occurrence of FIGO 2015 pathological CTG patterns showed a decreasing impact from bradycardia >10 min to decelerations >5 min, recurrent later or prolonged decelerations >30 min, and nonpathological CTG.…”
-
82617
Data_Sheet_1_Mechanical Determinants of the U-Shaped Speed-Energy Cost of Running Relationship.docx
Published 2018“…<p>Purpose: The aim of this study was to investigate the relationship between the energy cost of running (Cr) and speed and its mechanical determinants by comparing running in normal [100% body weight (BW)] and reduced (20% and 60% BW) gravity conditions at several speeds (2.25, 3.17, 4.08, and 5.00 m·s<sup>−1</sup>) in experienced runners.</p><p>Methods: Twelve experienced runners (24.6 ± 5.4 year) ran on an AlterG treadmill in a partially randomized order at the four running speeds and at the three gravity conditions in order to assess Cr, spatiotemporal parameters, spring-mass characteristics and elastic energy (EL) during running.…”
-
82618
Temporal Variation of Soil Physical Quality under Conventional and No-Till Systems
Published 2018“…Under NT, most dynamic indicators increase from BS to V6 and decrease again at AH, whereas under CT, they follow a different trend, decreasing from BS to V6, remaining constant until R5, and increasing at AH. …”
-
82619
Prediction of small for size syndrome after extended hepatectomy: Tissue characterization by relaxometry, diffusion weighted magnetic resonance imaging and magnetization transfer
Published 2018“…An increase in T2 time, again greater in ePH was most pronounced on day 5: 21% for cPH vs. 41% for ePH. ADC and MTR showed a decrease on day 1: 21% for ePH vs. 13% for cPH for ADC, 15% for ePH vs. 11% for cPH for MTR. …”
-
82620
Randomized clinical trials in dentistry: Risks of bias, risks of random errors, reporting quality, and methodologic quality over the years 1955–2013
Published 2017“…Two thirds of the trials were not described as double blinded (n = 358; 66.3%), while the method of blinding was appropriate in 53% (n = 286) of the trials. We identified a significant decrease over time (1955–2013) in the proportion of trials assessed as having inadequately addressed methodological quality items (P < 0.05) in 30 out of the 40 quality criteria, or as being inadequate (at high or unclear risk of bias) in five domains of the Cochrane risk of bias tool: sequence generation, allocation concealment, incomplete outcome data, other sources of bias, and overall risk of bias.…”